We have an in-person interview for you today! We sit down with Dr. Adil Daud of UCSF to talk all things melanoma. We cover Tebentafusp, nodal dissection, the Will Rogers phenomenon and the effect of stage migration on clinical trials as imaging advances, adjuvant vs I/O, academic training vs apprenticeship for budding oncologists, and more!

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version

Asco Prequel - We talk about what to look for

Should trials have carbon footprint as an endpoint?

A SM crossover - Cifu, Prasad, Mandrola

My grand rounds; Beta blockers post MI
Single center vs multicenter RCT
Masks
Boosters and more

When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai

I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year

4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud

Download our free app to listen on your phone